Updated: Tools

25 01 2021

There’s a slang term we heard recently, when a dope was referred to as a “tool.” We had to look it up and came up with this:

Someone who others normally refer to as a prick, dick, or schmuck.

Then there’s the version that is:

A guy with a hugely over-inflated ego, who in an attempt to get undue attention for himself, will act like a jackass, because, in his deluded state, he will think it’s going to make him look cool, or make others want to be like him….

Which brings us to Veera Prateepchaikul’s latest op-ed. Veera felt the need to boil over on the vaccine crisis. Veera, along with Somchai Jitsuchon, research director for inclusive development at the Thailand Development Research Institute, both defend the vaccine deal with the king’s company, Siam Bioscience.

Somchai said “he had come came across no evidence of Thailand paying too much, although he admitted he was no expert in the subject.” Somchai is an adviser to Gen Prayuth Chan-ocha, a point not made by the Post. He did say “he did not know much about why Siam Bioscience Co was picked as local vaccine manufacturer for AstraZeneca,” but still defended the deal. You get the murky picture.

Veera, also no expert, and a sucker fish rather than an adviser, favored a more aggressive attack on Thanathorn Juangroongruangkit while posterior polishing the dead king.

After all that dirty work, Veera admitted that “Thanathorn raised a few valid questions about the vaccine deal between Siam Bioscience and Oxford-AstraZeneca,” which still haven’t been answered, but accused him of doing this “from the perspective of someone unaware of the background of the deal.” Now, this is an odd criticism when Thanathorn was raising questions about the secrecy and opacity of the deal.

Veera reckons Thanathorn “did not do his homework before talking publicly,” and essentially deserves a lese majeste charge or two.

Which brings us to Veera’s homework and here we don’t mean on how to polish royal ass while protecting your own. How’s Veera feeling about the Thai Enquirer report that “India offered to sell over 2 million doses of their AstraZeneca-licensed vaccine [but] was rejected by the Thai government…”?

How’s Veera feeling when he learns that:

According to sources within the Indian government, the offer to supply the same vaccine, at cost, to Thailand (up to 2 million doses initially) was also presented to Foreign Minister Don Pramudwinai but was rejected outright.

We don’t imagine that Don is an expert on vaccines either.

What does Veera think when he discovers: “The Ministry of Affairs … told Thai Enquirer that it was ‘better’ to get local vaccines ‘from the Ministry of Public Health or the vaccine institute’.” Which institute would that be?

How’s Veera going with political analyst Arun Saronchai’s comment?:

“I think you’re seeing this dogmatic and stubborn approach because there are people that stand to benefit from the government maintaining its course and insisting on locally-produced AstraZeneca vaccines and importing SinoVac vaccines.”

Of course, this leads back to Siam Bioscience and CP investment in the China shot.

How is that Veera’s royalist homework didn’t lead to this:

According to local news reports and whistleblower statements from inside the government, Thailand is set to pay up to 60 per cent more per dose for both the SinoVac vaccine and the Astrazeneca vaccine drawing criticisms of corruption and embezzlement from the opposition parties.

Meanwhile, confirming that lack of transparency, the erratic Deputy Prime Minister and Public Health Minister Anutin Charnvirakul responded to Thanathorn’s “call for the government to make public the contract signed between AstraZeneca and Siam Bioscience, the local vaccine-making factory, saying that was impossible as both parties were private companies, not organisations under the government.” So how’s the deal work then and why is the government defending it so vigorously. And so the circle is completed….

Update: Remarkably, the Post has published what looks like a paid-PR effort by Siam Bioscience, which reproduces the limited information provided at its website. Interestingly, the company explains its lack of preparedness and tells of “the deal”:

The mission to manufacture this COVID-19 vaccine is supported by the National Vaccine Institute, Ministry of Public Health, with a budget of almost 600 million baht, with an additional 100 million baht budgeted by Siam Cement Group (SCG). This will enable preparation of the manufacturing facilities and processes. In return for the government support, Siam Bioscience will procure the AstraZeneca vaccine with a value equivalent to the funding it receives and will give the vaccine to the Thai government to support vaccine availability to the public.

Clearly, the regime must now release the details of the agreements made as this statement raises all kinds of issues that cannot be resolved when transparency is not provided.


Actions

Information

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.




%d bloggers like this: